Panbela Therapeutics Announces Public Offering Pricing
Company Announcements

Panbela Therapeutics Announces Public Offering Pricing

Panbela Therapeutics (PBLA) has released an update to notify the public and investors about a regulation fd disclosure.

On January 29, 2024, the Company announced the pricing of its Public Offering via a press release. The contents of the press release, while provided for informational purposes, are not considered legally filed with the Securities and Exchange Commission under Section 18 of the Securities Exchange Act of 1934 and are not liable under that section. Additionally, the information is not to be included in any filings unless explicitly referenced.

For further insights into PBLA stock, check out TipRanks’ Stock Analysis page.

Related Articles
Christine BrownPBLA Upcoming Earnings Report: What to Expect?
TheFlyPanbela announces first patient enrolled in dose escalation study of CPP-1X-S
Christine BrownIs PBLA a Buy, Before Earnings?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App